Rational Use of Anti-Tuberculosis Drugs in the Chemotherapy Era of Drug-Resistant Tuberculosis
Wei Sha and Heping Xiao*
Tongji University School of Medicine, Shanghai Tuberculosis (lungs) Key Laboratory, Shanghai, China
- Corresponding Author:
- Heping Xiao
Department of Tuberculosis
Shanghai Pulmonary Hospital
Tongji University School of Medicine
Shanghai, China, 200433
E-mail: [email protected]
Received Date: May 27, 2014; Accepted Date: July 28, 2014; Published Date: August 10, 2014
Citation: Sha W and Xiao H (2014) Rational Use of Anti-Tuberculosis Drugs in the Chemotherapy Era of Drug-Resistant Tuberculosis. J Mycobac Dis 4:163. doi:10.4172/2161-1068.1000163
Copyright: © 2014 Sha W, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
The rational use of existing anti-TB drugs to design a regimen with high efficacy is the premise and guarantees to prevent the occurrence of acquired drug-resistance. The fundamental element is not only to follow the label strictly, but also to give patients off-label use of some drugs according to the principles of guidelines and reliable clinical trial evidences.